AzTrials
AzTrials

DeliriumNCT05732584

Effect of Auditory Stimulation by Family Voices in Preventing Delirium: A Randomized Controlled Trial

A study testing structured family voice stimulation and unstructured family voice stimulation in people with Delirium, run by Second Affiliated Hospital, Zhejiang University, School of Medicine at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Delirium is an acute cerebral dysfunction syndrome characterized by acute fluctuating changes in consciousness, cognitive dysfunction, and disorientation. It's especially common in critically ill patients of emergency intensive care units and seriously threatens the survival and prognosis of patients and causes heavy… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Delirium
What is being tested?
structured family voice stimulation and unstructured family voice stimulation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
213 participants
Where
1 siteChina
Study dates
25 Mar 2023to 15 Nov 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • transferred to the EICU from emergency admission
  • no other history of emergency, surgery, or ICU admission history within 30 days
  • no delirium in the first screening of Emergency Intensive Care Unit(EICU) admission
  • with an expected length of stay in EICU longer than 24h and use of sedation medication

Who cannot join

  • Presence of hearing impairment, severe dementia, psychiatric disorder, or other severe brain dysfunction that hinders delirium assessment
  • persistent coma or deep sedation (RASS score of -4 to -5)
  • patients without a family member who can cooperate with the recording
  • external ear disease or surgery that hinders earphone wearing

Trial locations and contacts

1 site in 1 country.

China1 site
  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    Hangzhou, Zhejiang, 310009

Other trials in China

About this study

Official title: Effect of Auditory Stimulation by Family Voices in Preventing Delirium Among Sedative Patients in Emergency Intensive Care Units :A Randomized Controlled Trial

Delirium is an acute cerebral dysfunction syndrome characterized by acute fluctuating changes in consciousness, cognitive dysfunction, and disorientation. It's especially common in critically ill patients of emergency intensive care units and seriously threatens the survival and prognosis of patients and causes heavy economic burdens to the family, society, and medical service system. Impaired verbal communication, unfamiliar medical personnel, physical restraint, spatial-temporal disorientation, mechanical ventilation and sedation medication use can lead to a lack of adequate sensory stimulation and a high risk of delirium. Acoustic stimulation as a non-invasive non-pharmacological intervention can provide some sensory stimulation as a surrogate for critically ill patients. This research designs the content scripts from the needs of ICU patients and families for sound stimulation. The goal of this randomized controlled study is to test the effect of auditory stimulation by family voices in preventing delirium among sedative patients in emergency Intensive care units.

Read the detailed description

Patients are separated from their families and society under the closed management of the intensive care unit, the use of sedative drugs, mechanical ventilation, impaired verbal communication, physical restraint, environmental noise, and prolonged light exposure, which lead to a lack of adequate sensory stimulation, causing sensory deprivation in patients to some extent. In turn, sensory deprivation may cause multisensory perceptual confusion and hallucinations, affecting patients' orientation and thinking and triggering delirium, so providing appropriate sensory stimulation to critically ill patients may help to improve patients' orientation and attention, correct patients' thinking confusion and prevent delirium, and in clinical practice, sensory stimulation is considered as an important part of multicomponent delirium prevention programs.

Conditions
Delirium
Being tested
structured family voice stimulation, unstructured family voice stimulation
Keywords
Delirium, Intensive Care Units, Auditory Stimulation
Medical subject headings
Delirium

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • structured family voice stimulationOther

    The structured family voice stimulation is played to the patients for the first five days after admission to eicu until transfer out or death. The content of the recording is developed according to the structured script.

  • unstructured family voice stimulationOther

    The unstructured family voice stimulation is played to the patients for the first five days after admission to eicu until transfer out or death.

Study groups in NCT05732584
Study groupRoleWhat they receive
structured family voice stimulationExperimentalPatients in this group were provided with structured family voice stimulation
Receives: Other: structured family voice stimulation
unstructured family voice stimulationExperimentalPatients in this group were provided with unstructured family voice stimulation
Receives: Other: unstructured family voice stimulation
Control groupNo interventionPatients in this group will receive no specific voice stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. incidence of delirium

    use the Confusion Assessment Method for the ICU (CAM-ICU)

    Measured: up to 5 days

Secondary outcomes (8)
  1. delirium severity

    use Confusion Assessment Method for the Intensive Care Unit 7-item (CAM-ICU-7), ranging from 0-7 , higher scores means higher delirium severity.

    Measured: up to 5 days

  2. delirium duration

    use the Confusion Assessment Method for the ICU (CAM-ICU)

    Measured: up to 5 days

  3. delirium-free days

    use the Confusion Assessment Method for the ICU (CAM-ICU)

    Measured: up to 5 days

  4. delirium subtype

    use the Confusion Assessment Method for the ICU (CAM-ICU) and Richmond Agitation Sedation Scale(RASS)

    Measured: up to 5 days

  5. time to first delirium

    use the Confusion Assessment Method for the ICU (CAM-ICU)

    Measured: up to 5 days

  6. family anxiety levels

    families were assessed using the Self-Rating Anxiety Scale (SAS) at the beginning and at the end of the intervention. (The score ranges from 25 to 100 and higher scores means more anxious situation)

    Measured: up to 5 days

  7. family depression levels

    families were assessed using the Self-Rating Depression Scale (SDS) at the beginning and at the end of the intervention. (The score ranges from 25 to 100 and higher scores means more depressed situation)

    Measured: up to 5 days

  8. Duration of mechanical ventilation

    Duration of use of mechanical ventilation

    Measured: up to 5 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Feb 2023
  2. Study start25 Mar 2023
  3. Primary completion15 Nov 2023
  4. Study completion15 Nov 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
213 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05732584
Sponsor's protocol ID
2022-1013
Status last verified
Feb 2023
First submitted
8 Feb 2023
Last updated
28 Feb 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing structured family voice stimulation and unstructured family voice stimulation in people with Delirium, run by Second Affiliated Hospital, Zhejiang University, School of Medicine at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

incidence of delirium (time frame: up to 5 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT05732584 | AzTrials